Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Graphical Abstract The increasing use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) raises concern about potential interactions with narrow therapeutic index medications such as warfarin
Purpose-built for physicians Addiction, depression, cognition: How GLP-1s may benefit the brain Key takeaways: There is evidence that GLP-1s can ameliorate psychiatric and neurologic symptoms
TRPV1 antagonists that cause hypothermia, instead of hyperthermia, in rodents: compounds pharmacological profiles, in vivo targets, thermoeffectors recruited and implications for drug development
& Scribani, M
What should patients do if they can no longer access compounded GLP-1 medications
US$ 22.28
US$ 23.76
US$ 27.52
US$ 26.46
US$ 27.38
